|

Targeted agent Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Prince of Songkla University1
  • Medical College of Wisconsin1

Indications

  • Cancer2
  • Sarcopenia1
  • Advanced Lung Cancer1
  • Lung Cancer1

Other1 trial

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

Milwaukee, Wisconsin1 trial

Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses

Froedtert Hospital & the Medical College of Wisconsin

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.